Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Dihydrocaffeic acid
Cat. No.:
0225LY-1401
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Dihydrocaffeic acid serves as a metabolic derivative of chlorogenic acid, functioning as a recognized antioxidant with diverse therapeutic potentials including lipid-lowering, arousal-promoting, neuroprotective, and anti-Alzheimer's disease effects.
Synonym:
Hydrocaffeic acid; 1078-61-1; Dihydrocaffeic acid; 3-(3,4-Dihydroxyphenyl)propionic acid; 3-(3,4-Dihydroxyphenyl)propanoic acid; 3,4-Dihydroxyhydrocinnamic acid; 3,4-Dihydroxyphenylpropionic acid; Benzenepropanoic acid, 3,4-dihydroxy-; 3,4-Dihydroxybenzenepropanoic acid; 3,4-Dihydroxybenzenepropionic acid; 3,4-Dihydroxy-benzenepropanoic acid; Hydrocinnamic acid, 3,4-dihydroxy-; 3,4-Dihydroxydihydrocinnamic acid; 3,4-dihydroxyhydrocinnamate; 3,4-Dihydroxy-beta-phenylpropionic acid; 3-(3,4-dihydroxyphenyl) propionic acid; 3,4-Dihydroxyphenylpropanoate
CAS No.:
1078-61-1
Compound CID:
348154
Formula:
C9H10O4
Formula Weight:
182.17
Specification
Relative Density:
1.398 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dihydrocaffeic acid can be used in antioxidant research or play an important role in studies on the metabolic transformation of dietary polyphenols.
Library Information
Target:
p38 MAPK
Receptor:
p38 MAPK
Pathways:
Metabolism; Oxidation-reduction; MAPK
Plate Number:
AOCL-19
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
250 mg/mL; 1372.34 mM





